RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that it has been awarded a series of broad patents covering the use of metabolomics for disease biomarker discovery.
